Boston Scientific · 19 hours ago
R&D Tech IV
Boston Scientific is a leader in medical science committed to solving important health industry challenges. The R&D Tech IV role involves working with project teams to develop and analyze products, materials, processes, or equipment.
Health CareMedicalMedical Device
Responsibilities
Contribute original concepts to the development of advanced prototypes and fixtures
Apply engineering statistics software (i.e., DOE) to characterize processes
Create engineering drawings using Deneba Canvas Graphics and CAD Software and create complete R&D engineering documentation following established procedures. Write and/or verify specifications
Analyze data, calculate statistics, and prepares complete product test reports
Validate equipment and new processes
Maintain complex test equipment, train staff on its operations, and schedule necessary calibration or preventative maintenance
Actively participate in project team meetings. Coordinate and monitor project task execution and project progress against deliverables
Identify additional or new vendors to identify and acquire necessary supplies, materials, equipment and tools for specific projects
Qualification
Required
Minimum of 4 years of experience with a high school degree or an equivalent combination of education/work experience
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
H1B Sponsorship
Boston Scientific has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (114)
2024 (106)
2023 (93)
2022 (140)
2021 (111)
2020 (97)
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2025-12-25
2025-12-12
2025-12-11
Company data provided by crunchbase